These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34156257)

  • 1. Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.
    Tang HX; Yang H; Li F; Cao ZL; Huang YT; Qi XP
    Neoplasma; 2021 Sep; 68(5):1098-1106. PubMed ID: 34156257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
    Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis].
    Fang X; Wang H; Dong F; Lian B; Li F; Jin H; Yu Y; Zhang N; Qi X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Sep; 39(9):938-943. PubMed ID: 36082561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
    Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report.
    Li Y; Tan YQ; Tang ZX; Liao QH; Guo ZQ; Lai KB; Wang R; Chen YH
    Medicine (Baltimore); 2021 Jun; 100(22):e26230. PubMed ID: 34087905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
    Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
    Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
    Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-Onset Medullary Thyroid Cancer in a Patient with a Germline
    Walczyk A; Zgubieński K; Chmielewski G; Hińcza-Nowak K; Kowalik A; Jaskulski J; Kowalska A
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441382
    [No Abstract]   [Full Text] [Related]  

  • 17. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
    Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
    Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
    Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
    Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.